CAU Y1706 Novel Kazachstania turicensis CAU Y1706 and compositions using the same

摘要

The present invention relates to a novel Kazatsu Tania thurisensis CAU Y1706 and a composition using the same, and more particularly, Kazatsu Tania thurisensis CAU Y1706 (Accession No.: KCTC13794BP) strain, and the strain or a culture thereof are effective It relates to a pharmaceutical composition, food composition, cosmetic composition, and probiotic composition for the prevention or treatment of inflammatory diseases, including as ingredients. The novel yeast according to the present invention has anti-inflammatory activity by promoting Th2 immune response mediated by Tregs, has an intestinal effect, and is excellent in inhibiting inflammation in the skin and intestines with respect to the ovalbumin-sensitized mouse model. In addition, it has excellent acid resistance and bile resistance, so it has high commercial value.